Tokyo, Japan

Kazunari Kadokura

This inventor holds 1 USPTO granted patent. Top assignee: Kibun Foods Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunari Kadokura. Retrieved from https://idiyas.com/inventor/kazunari-kadokura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazunari Kadokura: Innovator in Dementia Treatment

Introduction

Kazunari Kadokura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for dementia. His work is crucial in addressing the growing concerns surrounding cognitive disorders.

Latest Patents

Kazunari Kadokura holds a patent for a therapeutic agent for dementia. This invention comprises a pharmaceutically active substance derived from his work at Kibun Foods Inc. The patent represents a step forward in the search for effective treatments for dementia, showcasing his innovative approach to healthcare.

Career Highlights

Throughout his career, Kadokura has focused on developing solutions that improve the quality of life for individuals suffering from dementia. His dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Kadokura has worked alongside talented colleagues, including Kohei Suruga and Yasuhiro Komatsu. Their collaborative efforts have contributed to advancements in the field and have fostered a productive research environment.

Conclusion

Kazunari Kadokura's work in developing a therapeutic agent for dementia highlights his commitment to innovation in healthcare. His contributions are vital in the ongoing battle against cognitive disorders, and his patent reflects the potential for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…